Search Results - "Arquiola, José María Paredes"

Impact of BMGIM Music Therapy on Emotional State in Patients with Inflammatory Bowel Disease: A Randomized Controlled Trial by March-Luján, Vicente Alejandro, Prado-Gascó, Vicente, Huguet, José María, Cortés, Xavier, Arquiola, José María Paredes, Capilla-Igual, María, Josefa-Rodríguez-Morales, María, Monzó-Gallego, Ana, Armero, José Luis Platero, Ortí, José Enrique de la Rubia

“…Patients with inflammatory bowel disease (IBD) have a high prevalence of emotional disturbances which worsen the symptoms of the disease. As a therapeutic…”
Get full text

Evaluation of changes in intestinal microbiota in Crohn’s disease patients after anti-TNF alpha treatment by Sanchis-Artero, Laura, Martínez-Blanch, Juan Francisco, Manresa-Vera, Sergio, Cortés-Castell, Ernesto, Valls-Gandia, Marina, Iborra, Marisa, Paredes-Arquiola, Jose Maria, Boscá-Watts, Maia, Huguet, Jose Maria, Gil-Borrás, Rafael, Rodríguez-Morales, Josefa, Cortés-Rizo, Xavier

“…Intestinal dysbiosis is key in the onset and development of Crohn’s disease (CD). We evaluated the microbiota changes in CD patients before and after a…”
Get full text

Clinical utility of serum concentrations of adalimumab as predictor of treatment adherence by Sáez Belló, Marina, Llopis Salvia, Pilar, Alegre Sancho, Juan José, Paredes Arquiola, José María, Asencio Muñoz, M. del Carmen, Climente Martí, Mónica

“…To evaluate the usefulness of serum concentrations (Sc) of adalimumab (ADA) as a predictor of medication adherence using the medication possession ratio (MPR)…”
Get full text

Ultrasonography and Transmural Healing in Crohn’s Disease by Ripollés, Tomás, MD, Paredes Arquiola, Jose Maria, MD, Moreno-Osset, Eduardo, MD

Get full text

Utilidad de las concentraciones séricas de adalimumab como predictores de adherencia al tratamiento by Sáez Belló, Marina, Llopis Salvia, Pilar, Alegre Sancho, Juan José, Paredes Arquiola, José María, Asencio Muñoz, M. del Carmen, Climente Martí, Mónica

“…Evaluar la utilidad de la determinación de concentraciones séricas (Cs) de adalimumab (ADA) como factor predictor de la adherencia al fármaco medida a través…”
Get full text

Clinical utility of serum concentrations of adalimumab as predictor of treatment adherence by Sáez Belló, Marina, Llopis Salvia, Pilar, Alegre Sancho, Juan José, Paredes Arquiola, José María, Asencio Muñoz, M Del Carmen, Climente Martí, Mónica

“…to evaluate the usefulness of serum concentrations (Sc) of adalimumab (ADA) as a predictor of medication adherence using the medication possession ratio (MPR)…”
Get more information